Nami Pandit‐Abid

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma

Lawrence Sher, Michael E. Wechsler, Klaus F. Rabe et al. · CHEST Journal · 2022 · 44 citations · Full text

Pharmacy, Immunology, Pharmacology +11

Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies

Bob Geng, Claus Bachert, William W. Busse et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

Ian Pavord, Klaus F. Rabe, Elliot Israel et al. · The Journal of Allergy and Clinical Immunology In Practice · 2024 · 35 citations · Full text

Medicine, Immunology, Pharmacology +9

Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps

Patrick Berger, Andrew Menzies‐Gow, Anju T. Peters et al. · Annals of Allergy Asthma & Immunology · 2022 · 27 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

Klaus F. Rabe, J. Mark FitzGerald, Eric D. Bateman et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 24 citations

Life Sciences, Immunology, Pharmacology +9